Platelet Function Disorders and Genetic Variants

Platelets play a central role in primary haemostasis by adhering to damaged endothelium, activating signalling cascades and aggregating to form a haemostatic plug. Platelet function disorders encompass a spectrum of inherited and acquired defects in membrane receptors, intracellular signalling pathways and granule secretion mechanisms. At the genetic level, congenital thrombocytopathies often result from pathogenic variants in genes encoding key glycoprotein complexes (for example ITGA2B and ITGB3 in Glanzmann thrombasthenia, or GP1BA in Bernard–Soulier syndrome), or in proteins governing granule formation and release. Advances in high-throughput sequencing have greatly expanded the catalogue of disease-causing mutations, revealing population-specific founder effects and novel alleles that modulate bleeding severity. Clinically, these disorders present with mucocutaneous bleeding, menorrhagia and risk of perioperative haemorrhage. Diagnostic work-up integrates platelet count, morphology, aggregometry and flow cytometry, complemented by targeted genetic panels. A deeper understanding of molecular mechanisms has spurred the development of tailored therapies—including recombinant factor VIIa, antifibrinolytic agents and emerging gene-based approaches—ushering in an era of personalised management for affected individuals worldwide.

Research from Nature Portfolio

Recent studies have employed molecular dynamics simulations to investigate the structural consequences of missense mutations within the Calf-1 domain of the platelet integrin αIIbβ3 complex. These analyses have revealed that seemingly local substitutions can induce unexpected long-range conformational changes and alter regional flexibility, challenging conventional models of allosteric regulation. By mapping deformable zones and rigid segments within the Calf-1 domain, this work provides a foundational framework for predicting the impact of novel variants on integrin expression and function, and supports the rational design of virtual screening approaches for small-molecule modulators.

Platelet Function Disorders and Genetic Variants publication trend

The graph below shows the total number of articles in platelet function disorders and genetic variants across all publications each year (not limited to Nature Index journals).

Technical terms

Platelet aggregation: the process by which platelets adhere to one another via fibrinogen bridges, forming a haemostatic plug.

Integrin αIIbβ3: a receptor on platelet surfaces that binds fibrinogen and von Willebrand factor to mediate aggregation.

Glanzmann thrombasthenia: a congenital bleeding disorder caused by qualitative or quantitative defects in αIIbβ3, leading to impaired platelet aggregation.

Missense mutation: a single nucleotide change in DNA that substitutes one amino acid for another in the encoded protein.

Allostery: the regulation of a protein’s activity through conformational changes induced by ligand binding or mutations at sites distant from the active region.

References

1. In silico analysis of Glanzmann variants of Calf-1 domain of αIIbβ3 integrin revealed dynamic allosteric effect. Scientific Reports (2017).
2. Glanzmann Thrombasthenia in Pakistani Patients: Identification of 7 Novel Pathogenic Variants in the Fibrinogen Receptor αIIbβ3. Cells (2023).
3. Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders. Orphanet Journal of Rare Diseases (2023).
4. Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia. Frontiers in Pediatrics (2023).